Cervical Cancer Clinical Trials in Beijing
10 recruitingBeijing, China
Showing 1–10 of 10 trials
Recruiting
Phase 3
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
AstraZeneca800 enrolled201 locationsNCT06079671
Recruiting
Phase 1
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Triple-Negative Breast CancerEsophageal CancerPancreatic Cancer+11 more
Eli Lilly and Company490 enrolled28 locationsNCT06238479
Recruiting
Phase 2
Online Adaptive Radiotherapy for Cervical Cancer
Cervical Cancer
Peking Union Medical College Hospital124 enrolled1 locationNCT06562166
Recruiting
Not Applicable
The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients
Cervical Cancers
SHUANG ZHENG JIA, PhD50 enrolled1 locationNCT06349148
Recruiting
Phase 2
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
LOCALLY ADVANCED CERVICAL CANCERS
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT07232654
Recruiting
Phase 2
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Cervical CancerHead and Neck Squamous Cell Carcinoma
AstraZeneca110 enrolled50 locationsNCT06535607
Recruiting
Not Applicable
Modified Tumor-free Techniques Operation to Cervical Cancer
Cervical Cancer Stage IB2
Peking Union Medical College Hospital524 enrolled13 locationsNCT06836869
Recruiting
Phase 3
Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
Cervical CancerAdaptive Radiotherapy
Peking Union Medical College Hospital440 enrolled1 locationNCT06641635
Recruiting
Phase 2
Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer
Cervical CancerPET/CTRadiotherapy+2 more
Peking Union Medical College Hospital51 enrolled1 locationNCT06353061
Recruiting
Phase 3
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.420 enrolled2 locationsNCT06692166